OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alleviating hypoxia to improve cancer immunotherapy
Peng Fan, Naidong Zhang, Eleonora Candi, et al.
Oncogene (2023) Vol. 42, Iss. 49, pp. 3591-3604
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Metabolic memory: mechanisms and diseases
Hao Dong, Yuezhang Sun, Lulingxiao Nie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30

Targeting the tumour vasculature: from vessel destruction to promotion
Sophie Guelfi, Kairbaan Hodivala‐Dilke, Gabriele Bergers
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 655-675
Closed Access | Times Cited: 27

Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy
Fotios Mpekris, Myrofora Panagi, Antonia Charalambous, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101626-101626
Open Access | Times Cited: 10

Tumour‐Associated Macrophages in Oral Squamous Cell Carcinoma
Akhilanand Chaurasia, Carel Brigi, Arwa Daghrery, et al.
Oral Diseases (2025)
Closed Access | Times Cited: 1

Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective
Yang Xiao, Yongsheng Li, Huakan Zhao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7

The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention
Adriana Albini, Douglas M. Noonan, Paola Corradino, et al.
Cancer Prevention Research (2024) Vol. 17, Iss. 7, pp. 289-303
Closed Access | Times Cited: 6

Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach
Clara Bayona, Lía Alza, Teodora Ranđelović, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 4

Hypoxic tumor microenvironment: Destroyer of natural killer cell function
Yongfei Zhang, Feifei Guo, Yufeng Wang
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 138-150
Open Access | Times Cited: 4

Brachytherapy: Perspectives for combined treatments with immunotherapy
Raphaël Serre, Alexandra Gabro, Mickael Andraud, et al.
Clinical and Translational Radiation Oncology (2025), pp. 100924-100924
Open Access

Acquired resistance to immunotherapy in solid tumors
Perrine Verdys, Astrid Z. Johansen, Anurag Gupta, et al.
Trends in Molecular Medicine (2025)
Closed Access

Hemoglobin-loaded hollow mesoporous carbon-gold nanocomposites enhance microwave ablation through hypoxia relief
Yitian Zhang, Bingge Li, Jiawen He, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

Deciphering the role of circular RNAs in cancer progression under hypoxic conditions
Hamza Abu Owida, Raed Obaid Saleh, Suleiman Ibrahim Shelash Mohammad, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access

Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy
Concetta Meo, Filomena de Nigris
Cancers (2024) Vol. 16, Iss. 3, pp. 491-491
Open Access | Times Cited: 3

Highly efficient tumor oxygen supplementation MnO2 nano-MOF encapsulated Sorafenib for multiple synergistic CDT/PDT/RT
Shuangshuang Guo, Miaomiao Chen, Yuhao Yang, et al.
International Journal of Pharmaceutics (2025), pp. 125328-125328
Closed Access

Unveiling hypoxia-related prognostic and immunotherapeutic biomarkers in lung adenocarcinoma through single-cell and bulk RNA sequencing: Including insights into PGF
Shengqiang Mao, Lü Chen, Qingyan Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 309, pp. 143056-143056
Closed Access

Reengineering the Tumor Oxygen Microenvironment in Radiotherapy to Enhance T‐Cell Function for Radio‐Immunotherapy
Zetong Chen, Qing‐Yu He, Rui Qian, et al.
Advanced Functional Materials (2025)
Closed Access

The development process of ‘fit-for-purpose’ imaging biomarkers to characterize the tumor microenvironment
Jakoba J. Eertink, Idris Bahce, John C. Waterton, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors
ZhouXue Wu, Junru Chen, Biqiong Wang, et al.
Chemical Engineering Journal (2024), pp. 158081-158081
Closed Access | Times Cited: 3

Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies
Rahamat Unissa Syed, Maali D. Alshammari, Humera Banu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7421-7437
Closed Access | Times Cited: 2

U-Shape Pillar Strip for 3D Cell-Lumped Organoid Model (3D-COM) Mimicking Lung Cancer Hypoxia Conditions in High-Throughput Screening (HTS)
Sang‐Yun Lee, Eunyoung Lee, Jeong Uk Lim, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 25, pp. 10246-10255
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top